Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Eyepoint, Inc.
13G
EYPT · 30233G209
|
10.9% |
9/8/2026
Event 8/31/2026
|
|||
|
Vogenx, Inc.
13G
VOGX · 92859A106
|
13.0% |
9/8/2026
Event 8/31/2026
|
|||
|
Teleflex Incorporated
13G/A
TFX · 879369106
|
10.3% |
9/8/2026
Event 8/31/2026
|
|||
| JANUS HENDERSON GROUP Ltd. | 10.3% | ||||
| Janus Henderson Enterprise Fund | 6.8% | ||||
|
Ziff Davis, Inc.
13G/A
ZD · 48123V102
|
10.3% |
9/8/2026
Event 8/31/2026
|
|||
|
Mirum Pharamaceuticals, Inc.
13G/A
MIRM · 604749101
|
9.7% |
8/13/2026
Event 6/30/2026
|
|||
|
Forte Biosciences, Inc.
13G/A
FBRX · 34962G208
|
9.3% |
8/13/2026
Event 6/30/2026
|
|||
|
Assembly Biosciences, Inc.
13G/A
ASMB · 045396207
|
6.9% |
8/13/2026
Event 6/30/2026
|
|||
|
Tarsus Pharmaceuticals, Inc.
13G/A
TARS · 87650L103
|
6.5% |
8/13/2026
Event 6/30/2026
|
|||
|
Dyne Therapeutics Inc
13G/A
DYN · 26818M108
|
7.3% |
8/13/2026
Event 6/30/2026
|
|||
|
Protara Therapeutics, Inc.
13G/A
TARA · 74365U107
|
8.4% |
8/13/2026
Event 6/30/2026
|
|||
|
Icu Medical, Inc.
13G/A
ICUI · 44930G107
|
11.1% |
8/13/2026
Event 6/30/2026
|
|||
|
Immix Biopharma, Inc.
13G/A
IMMX · 45258H106
|
14.0% |
8/13/2026
Event 6/30/2026
|
|||
|
Janux Therapeutics, Inc.
13G/A
JANX · 47103J105
|
0.3% |
8/13/2026
Event 6/30/2026
|
|||
|
Flex Ltd.
13G/A
FLEX · Y2573F102
|
3.8% |
8/13/2026
Event 6/30/2026
|
|||
|
Bicara Therapeutics Inc.
13G/A
BCAX · 055477103
|
4.8% |
8/13/2026
Event 6/30/2026
|
|||
|
Bel Fuse Inc.
13G/A
BELFB · 077347300
|
4.8% |
8/13/2026
Event 6/30/2026
|
|||
|
Ocugen, Inc.
13G/A
OCGN · 67577C105
|
3.0% |
8/13/2026
Event 6/30/2026
|
|||
|
Revolution Medicines, Inc.
13G
RVMD · 76155X100
|
5.1% |
8/13/2026
Event 6/30/2026
|
|||
|
Achieve Life Sciences, Inc.
13G
ACHV · 004468500
|
5.4% |
8/13/2026
Event 6/30/2026
|
|||
|
Inspired Entertainment, Inc.
13G
INSE · 45782N108
|
5.0% |
8/13/2026
Event 6/30/2026
|
|||
|
LPL Financial Holdings Inc.
13G
LPLA · 50212V100
|
5.3% |
8/13/2026
Event 6/30/2026
|
|||
|
Osi Systems, Inc.
13G
OSIS · 671044105
|
5.5% |
8/13/2026
Event 6/30/2026
|
|||
|
Jatt II Acquisition Corp.
13G
JATT · G50765109
|
6.2% |
8/13/2026
Event 6/30/2026
|
|||
|
Vaxcyte, Inc.
13G/A
PCVX · 92243G108
|
12.1% |
8/11/2026
Event 7/31/2026
|
|||
|
Yarrow Bioscience, Inc.
13G
YARW · 92941V407
|
10.0% |
8/7/2026
Event 7/31/2026
|
|||
|
Privacore VPC Asset Backed Credit Fund
13G
74291E300
|
17.1% |
7/8/2026
Event 6/30/2026
|
|||
|
Privacore Pcaam Alternative Growth Fund
13G
74290Y307
|
46.8% |
7/8/2026
Event 6/30/2026
|
|||
|
Privacore Pcaam Alternative Income Fund
13G
74291A308
|
67.4% |
7/8/2026
Event 6/30/2026
|
|||
|
Biohaven Ltd.
13G/A
BHVN · G1110E107
|
5.7% |
7/8/2026
Event 6/30/2026
|
|||
|
Jade Biosciences, Inc.
13G/A
JBIO · 008064206
|
10.6% |
7/8/2026
Event 6/30/2026
|
|||
|
Cellectar Biosciences, Inc.
13G
CLRB · 15117F880
|
10.0% |
6/5/2026
Event 5/29/2026
|
|||
|
Tyra Biosciences, Inc
13G/A
TYRA · 90240B106
|
7.2% |
5/15/2026
Event 3/31/2026
|
|||
|
PTC Therapeutics, Inc.
13G/A
PTCT · 69366J200
|
8.7% |
5/15/2026
Event 3/31/2026
|
|||
|
Olema Pharmaceuticals, Inc.
13G/A
OLMA · 68062P106
|
8.2% |
5/15/2026
Event 3/31/2026
|
|||
|
Lantheus Holdings, Inc.
13G/A
LNTH · 516544103
|
7.4% |
5/15/2026
Event 3/31/2026
|
|||
|
Maze Therapeutics, Inc.
13G/A
MAZE · 578784100
|
5.8% |
5/15/2026
Event 3/31/2026
|
|||
|
Madrigal Pharmaceuticals, Inc.
13G/A
MDGL · 558868105
|
8.8% |
5/15/2026
Event 3/31/2026
|
|||
|
Ideaya Biosciences, Inc.
13G/A
IDYA · 45166A102
|
8.3% |
5/15/2026
Event 3/31/2026
|
|||
|
Glaukos Corp
13G/A
GKOS · 377322102
|
9.2% |
5/15/2026
Event 3/31/2026
|
|||
|
Gildan Activewear Inc
13G/A
GIL · 375916103
|
5.7% |
5/15/2026
Event 3/31/2026
|
|||
|
Bright Minds Biosciences Inc.
13G/A
DRUG · 10919W405
|
13.1% |
5/15/2026
Event 3/31/2026
|
|||
|
Bridgebio Pharma, Inc.
13G/A
BBIO · 10806X102
|
6.8% |
5/15/2026
Event 3/31/2026
|
|||
|
Ascendis Pharma A/S
13G/A
ASND · 04351P101
|
6.0% |
5/15/2026
Event 3/31/2026
|
|||
|
Minerva Neurosciences, Inc.
13G
NERV · 603380205
|
9.9% |
5/15/2026
Event 3/31/2026
|
|||
|
Longeveron Inc.
13G
LGVN · 54303L203
|
5.9% |
5/15/2026
Event 3/31/2026
|
|||
|
Stride, Inc.
13G
LRN · 86333M108
|
5.4% |
5/15/2026
Event 3/31/2026
|
|||
|
Edgewise Therapeutics, Inc.
13G
EWTX · 28036F105
|
5.5% |
5/15/2026
Event 3/31/2026
|
|||
|
Collegium Pharmaceutical, Inc.
13G
COLL · 19459J104
|
5.8% |
5/15/2026
Event 3/31/2026
|
|||
|
Dayforce, Inc.
13G/A
DAY · 15677J108
|
0% |
5/15/2026
Event 3/31/2026
|
|||
|
Ardelyx, Inc.
13G/A
ARDX · 039697107
|
3.4% |
5/15/2026
Event 3/31/2026
|
|||
|
Xenon Pharmaceuticals Inc.
13G/A
XENE · 98420N105
|
4.5% |
5/15/2026
Event 3/31/2026
|
|||
|
SS&C Technologies Holdings, Inc.
13G/A
SSNC · 78467J100
|
3.5% |
5/15/2026
Event 3/31/2026
|
|||
|
Soleno Therapeutics, Inc.
13G/A
SLNO · 834203309
|
2.3% |
5/7/2026
Event 4/30/2026
|
|||
|
Adagene Inc.
13G
ADAG · 005329107
|
10.1% |
5/7/2026
Event 4/30/2026
|
|||
|
Promis Neurosciences Inc.
13G
PMN · 74346M505
|
14.4% |
4/7/2026
Event 3/31/2026
|
|||
|
4D Molecular Therapeutics, Inc.
13G/A
FDMT · 35104E100
|
10.3% |
4/7/2026
Event 3/31/2026
|
|||
|
Cimpress PLC
13G/A
CMPR · G2143T103
|
14.7% |
2/17/2026
Event 12/31/2025
|
|||
| Janus Henderson Group PLC | 14.7% | ||||
| Janus Henderson Enterprise Fund | 9.6% | ||||
|
Contineum Therapeutics, Inc.
13G
CTNM · 21217B100
|
7.9% |
2/17/2026
Event 12/31/2025
|
|||
|
Draftkings Inc.
13G
DKNG · 26142V105
|
5.1% |
2/17/2026
Event 12/31/2025
|
|||
|
Vistagen Therapeutics, Inc.
13G/A
VTGN · 92840H400
|
0% |
2/17/2026
Event 12/31/2025
|
|||
|
Sensient Technologies Corporation
13G/A
SXT · 81725T100
|
4.9% |
2/17/2026
Event 12/31/2025
|
|||
|
Metsera, Inc.
13G/A
MTSR · 59267L107
|
3.1% |
2/17/2026
Event 12/31/2025
|
|||
|
Mereo Biopharma Group PLC
13G/A
MREO · 589492107
|
0% |
2/17/2026
Event 12/31/2025
|
|||
|
Akero Therapeutics, Inc.
13G/A
AKRO · 00973Y108
|
4.1% |
2/17/2026
Event 12/31/2025
|
|||
|
Avadel Pharmaceuticals PLC
13G/A
AVDL · G29687103
|
1.9% |
2/17/2026
Event 12/31/2025
|
|||
|
Avidity Biosciences, Inc.
13G/A
RNAM · 05370A108
|
4.6% |
2/17/2026
Event 12/31/2025
|
|||
|
Equillium, Inc.
13G/A
EQ · 29446K106
|
10.0% |
2/6/2026
Event 1/30/2026
|
|||
|
Relmada Therapeutics, Inc.
13G
RLMD · 75955J402
|
10.1% |
2/6/2026
Event 1/30/2026
|
|||
|
DBV Technologies S.A.
13G/A
DBV.PA · F2927N109
|
8.8% |
1/8/2026
Event 12/31/2025
|
|||
|
CAMP4 Therapeutics Corp
13G
CAMP · 13463J101
|
12.2% |
1/8/2026
Event 12/31/2025
|
|||
|
Tenax Therapeutics, Inc.
13G
TENX · 88032L605
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Pasithea Therapeutics Corp.
13G
KTTA · 70261F202
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Palisade Bio, Inc.
13G
PALI · 696389402
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
| Janus Henderson Group PLC | 10.0% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.0% | ||||
|
Palatin Technologies Inc
13G
PTN · 696077601
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
| Janus Henderson Group PLC | 10.0% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.6% | ||||
|
Ovid Therapeutics Inc.
13G
OVID · 690469101
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Lexeo Therapeutics, Inc.
13G/A
LXEO · 52886X107
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Inovio Pharmaceuticals, Inc.
13G/A
INO · 45773H409
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Immunic, Inc.
13G
IMUX · 4525EP101
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Biomea Fusion, Inc.
13G
BMEA · 09077A106
|
5.0% |
12/8/2025
Event 11/28/2025
|
|||
|
Benitec Biopharma Inc.
13G/A
BNTC · 08205P209
|
10.0% |
12/8/2025
Event 11/28/2025
|
|||
| Janus Henderson Group PLC | 10.0% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.1% | ||||
|
Travere Therapeutics, Inc
13G/A
TVTX · 89422G107
|
11.9% |
11/14/2025
Event 9/30/2025
|
|||
|
Monopar Therapeutics Inc
13G/A
MNPR · 61023L207
|
19.5% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 19.5% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 16.7% | ||||
|
Ligand Pharmaceuticals Incorporated
13G/A
LGND · 53220K504
|
5.3% |
11/14/2025
Event 9/30/2025
|
|||
|
Rentokil Initial PLC
13G/A
RKLIF · G7494G105
|
5.6% |
11/14/2025
Event 9/30/2025
|
|||
|
Asure Software Inc
13G/A
ASUR · 04649U102
|
6.1% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 6.1% | ||||
| Janus Henderson Venture Fund | 5.7% | ||||
|
Revvity, Inc.
13G/A
RVTY · 714046109
|
6.6% |
11/14/2025
Event 9/30/2025
|
|||
|
Sensata Technologies Holding PLC
13G/A
ST · G8060N102
|
6.9% |
11/14/2025
Event 9/30/2025
|
|||
|
Structure Therapeutics Inc
13G/A
GPCR · 86366E106
|
7.7% |
11/14/2025
Event 9/30/2025
|
|||
|
Liberty Media Corporation
13G/A
FWONK · 531229755
|
4.8% |
11/14/2025
Event 9/30/2025
|
|||
|
Surgery Partners, Inc.
13G/A
SGRY · 86881A100
|
10.2% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 10.2% | ||||
| Janus Henderson Contrarian Fund | 9.7% | ||||
|
Invivyd, Inc.
13G/A
IVVD · 00534A102
|
12.1% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 12.1% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 10.3% | ||||
|
Praxis Precision Medicines, Inc
13G/A
PRAX · 74006W207
|
12.3% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 12.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.2% | ||||
|
Consensus Cloud Solutions, Inc.
13G/A
CCSI · 20848V105
|
13.1% |
11/14/2025
Event 9/30/2025
|
|||
| Janus Henderson Group PLC | 13.1% | ||||
| Janus Henderson Triton Fund | 7.0% | ||||
|
Api Group Corp
13G
APG · 00187Y100
|
5.3% |
11/14/2025
Event 9/30/2025
|
|||
|
Verona Pharma PLC
13G/A
VRNA · 925050106
|
1.2% |
11/14/2025
Event 9/30/2025
|
|||
|
Amdocs Limited
13G/A
DOX · G02602103
|
2.3% |
11/14/2025
Event 9/30/2025
|
|||
|
Enanta Pharmaceuticals Inc
13G
ENTA · 29251M106
|
12.1% |
11/7/2025
Event 10/31/2025
|
|||
| Janus Henderson Group PLC | 12.1% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 10.6% | ||||
|
89bio, Inc.
13G/A
ETNB · 282559103
|
3.6% |
10/7/2025
Event 9/30/2025
|
|||
|
Aramark
13G/A
ARMK · 03852U106
|
6.9% |
8/14/2025
Event 6/30/2025
|
|||
|
WEX, Inc.
13G/A
WEX · 96208T104
|
11.3% |
8/14/2025
Event 6/30/2025
|
|||
| Janus Henderson Group PLC | 11.3% | ||||
| Janus Henderson Enterprise Fund | 7.3% | ||||